Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Original Research
Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,512 | Dovepress* | 6,604+ | 693 | 7,297 | |
| PubMed Central* | 908 | 286 | 1,194 | ||
| Totals | 7,512 | 979 | 8,491 | ||
| *Since 3 May 2021 | |||||
View citations on PubMed Central and Google Scholar